Literature DB >> 17460642

When good drugs go bad.

Kathleen M Giacomini1, Ronald M Krauss, Dan M Roden, Michel Eichelbaum, Michael R Hayden, Yusuke Nakamura.   

Abstract

Mesh:

Year:  2007        PMID: 17460642     DOI: 10.1038/446975a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  60 in total

Review 1.  Individualized medicine, health medicine, and constitutional theory in Chinese medicine.

Authors:  Qi Wang
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 2.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

3.  The bridging function of clinical pharmacology.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-09       Impact factor: 2.953

4.  Pharmacogenetics education in British medical schools.

Authors:  Jenny E Higgs; Julie Andrews; David Gurwitz; Katherine Payne; William Newman
Journal:  Genomic Med       Date:  2009-04-12

Review 5.  The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Klaus Lieb; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

6.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

7.  Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.

Authors:  Mei Liu; Eugenia Renne McPeek Hinz; Michael Edwin Matheny; Joshua C Denny; Jonathan Scott Schildcrout; Randolph A Miller; Hua Xu
Journal:  J Am Med Inform Assoc       Date:  2012-11-17       Impact factor: 4.497

8.  Exploring the relationship between drug side-effects and therapeutic indications.

Authors:  Ping Zhang; Fei Wang; Jianying Hu; Robert Sorrentino
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

Review 9.  Data-driven methods to discover molecular determinants of serious adverse drug events.

Authors:  A P Chiang; A J Butte
Journal:  Clin Pharmacol Ther       Date:  2009-01-28       Impact factor: 6.875

10.  Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.

Authors:  Lun Yang; Jian Chen; Lin He
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.